Written informed consent, type 2 diabetes, male and female > 18 years,treated with metformin ≥ 1000 mg/day and sulphonylurea at maximum tolerated dose (at least half of the maximum approved dose) or glimepiride at maximum tolerated dose (at least 2 mg/day) both at a stable dose for at least 90 days prior to screening.
HbA1c 7.0 % -10.0% inclusive.BMI ≥ 20 kg/m2.
Willing to fast Ramadan and give blood during Ramadan.